Cargando…
Third degree atrioventricular block associated with treatment with rivastigmine transdermal patch
Rivastigmine transdermal patch is indicated for patients with Alzheimer's disease and dementia with Parkinson's disease. Rivastigmine, an acetylcholinesterase inhibitor, has several common adverse effects, mainly involving the gastrointestinal tract, but few cardiovascular adverse effects...
Autores principales: | Knudtzen, Fredrikke C., Christophersen, Thomas B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Science Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3627713/ https://www.ncbi.nlm.nih.gov/pubmed/23610582 http://dx.doi.org/10.3969/j.issn.1671-5411.2013.01.017 |
Ejemplares similares
-
An Atypical Cutaneous Reaction to Rivastigmine Transdermal Patch
por: Grieco, T., et al.
Publicado: (2011) -
Preparation and Characterization of Rivastigmine Transdermal Patch Based on Chitosan Microparticles
por: Sadeghi, Mohsen, et al.
Publicado: (2016) -
Second-degree atrioventricular block type II and third-degree atrioventricular block requiring cardiac pacing after tooth extraction
por: Kishimoto, Naotaka, et al.
Publicado: (2015) -
Pharmacokinetics of a novel transdermal rivastigmine patch for the treatment of Alzheimer’s disease: a review
por: Kurz, A, et al.
Publicado: (2009) -
Metoprolol: Third degree atrioventricular block: 2 case reports
Publicado: (2021)